Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Transfusion needs after CAR T-cell therapy for large B-cell lymphoma: predictive factors and outcome (a DESCAR-T study)
Samuel Vic, Jean‐Baptiste Thibert, Emmanuel Bachy, et al.
Blood Advances (2024) Vol. 8, Iss. 6, pp. 1573-1585
Open Access | Times Cited: 10

Showing 10 citing articles:

Immune effector cell-associated haematotoxicity after CAR T-cell therapy: from mechanism to management
Kai Rejeski, Michael D. Jain, Nirali N. Shah, et al.
The Lancet Haematology (2024) Vol. 11, Iss. 6, pp. e459-e470
Closed Access | Times Cited: 26
Development and validation of an automated computational approach to grade immune effector cell-associated hematotoxicity
Emily C. Liang, Kai Rejeski, Teng Fei, et al.
Bone Marrow Transplantation (2024) Vol. 59, Iss. 7, pp. 910-917
Closed Access | Times Cited: 4
Can Allogeneic Transfusions Harm Patients Undergoing Cancer Surgery?
N. Blumberg, Shannon L. Farmer
Anesthesia & Analgesia (2025)
Closed Access
Mobilizing CARs: Benefits, Drawbacks, and Directions for Outpatient CAR T-cell therapy
Jennifer S. Woo, Kim-Anh Nguyen, Lawrence Liu, et al.
Seminars in Hematology (2024) Vol. 61, Iss. 5, pp. 273-283
Closed Access | Times Cited: 2
Optimization Strategies in CAR T-cell Therapy
Zaheer Qureshi, Faryal Altaf, Abdur Jamil, et al.
American Journal of Clinical Oncology (2024) Vol. 47, Iss. 12, pp. 607-615
Closed Access | Times Cited: 1
Navigating the prognostic role of transfusions after CAR-T
Mohammad Alhomoud, Kai Rejeski
Blood Advances (2024) Vol. 8, Iss. 6, pp. 1570-1572
Open Access
Toxicités hématologiques après CAR-T cells, recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)
Tamim Alsuliman, Clotilde Aubrun, Jacques Olivier Bay, et al.
Bulletin du Cancer (2024)
Closed Access
Delayed neutrophil recovery following BCMA CAR-T therapy in Duffy-null myeloma does not impact severe infections or survival
Zachary M. Avigan, Saoirse Bodnar, Darren Pan, et al.
Blood Advances (2024) Vol. 9, Iss. 1, pp. 202-206
Open Access
Development and validation of predictive models of early immune effector cell-associated hematotoxicity (eIPMs)
Emily C. Liang, Jennifer J. Huang, Andrew J. Portuguese, et al.
Blood Advances (2024)
Open Access
Terapia CAR-T y transfusión de plaquetas: un reto para los servicios de transfusión
Rosa Goterris-Viciedo
Revista Sangre (2024) Vol. 43, Iss. 92
Closed Access
Page 1

Scroll to top